rivastigmine has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bogerts, B; Bommhardt, U; Busse, M; Busse, S; Dobrowolny, H; Glorius, S; Greiner-Bohl, S; Hartig, R; Mawrin, C; Steiner, J | 1 |
1 review(s) available for rivastigmine and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for rivastigmine and sirolimus
| Article | Year |
|---|---|
VGF expression by T lymphocytes in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; CD3 Complex; Cell Proliferation; Cells, Cultured; Female; Flow Cytometry; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Male; Nerve Growth Factors; Neuroprotective Agents; Rivastigmine; Sirolimus; T-Lymphocytes | 2015 |